Takayuki Iwamoto
Kurashiki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
Peripheral Blood T-Cell Receptor Repertoire and Host Immune Background in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Journal: Acta medica Okayama
Published: June 30, 2026
Efficacy of adjuvant chemotherapy for triple-negative early breast cancer with tumor size ≤ 1 cm and node-negative from the National Clinical Database-Breast Cancer Registry in Japan.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 06, 2026
Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness).
Journal: Breast cancer (Tokyo, Japan)
Published: March 24, 2026
Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: February 12, 2026
Annual report of national clinical database-breast cancer registry in 2023: systemic therapy for small breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: January 28, 2026
Chemotherapy is associated with differential survival outcomes in apocrine carcinoma: A nationwide cohort study from the Japanese National Clinical Database-Breast Cancer Registry.
Journal: Breast (Edinburgh, Scotland)
Published: January 08, 2026
Risk factors and metastatic sites in HER2-positive breast cancer with pathological complete response.
Journal: NPJ breast cancer
Published: January 06, 2026
Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical Trial.
Journal: JAMA network open
Published: August 15, 2025
Annual report of National Clinical Database-Breast Cancer Registry in 2021: characteristics categorized by body mass index and menopause status.
Journal: Breast cancer (Tokyo, Japan)
Published: January 27, 2025
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry-clinical implications including chemosensitivity of breast cancer with low estrogen receptor expression.
Journal: Breast cancer (Tokyo, Japan)
Published: January 13, 2025
Validation of the Symptom Illustration Scale within an electronic Patient-Reported Outcomes Monitoring environment for metastatic breast cancer patients undergoing chemotherapy.
Journal: Breast cancer (Tokyo, Japan)
Published: December 17, 2024
Last Updated: 09/26/2026